Global Arthropod Borne Viral Infections Testing Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 1.14 Billion |
 Market Size (Forecast Year) |
USD 1.77 Billion |
 CAGR |
% |
| Major Markets Players |
>全球节肢动物传播病毒感染检测市场细分，按检测类型（分子检测、文化检测、免疫测定等）、最终用户（医院、研究中心和诊断中心）划分 - 行业趋势和 2031 年预测
节肢动物传播病毒感染检测市场分析
由于气候变化、城市化和国际旅行等因素，全球感染发病率不断上升，对准确、快速检测解决方案的需求也随之增加。市场上有各种诊断工具，包括分子检测、免疫测定和培养方法。最近的进展包括开发更灵敏、更便携的分子检测。此外，公共卫生机构和诊断公司之间的合作旨在提高全球应对能力，促进市场增长。
节肢动物传播病毒感染检测市场规模
2023 年全球节肢动物传播病毒感染检测市场规模价值 11.4 亿美元，预计到 2031 年将达到 17.7 亿美元，2024 年至 2031 年预测期内的复合年增长率为 5.65%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
节肢动物传播病毒感染检测市场趋势
“诊断技术的创新”
诊断技术创新（例如即时分子检测和免疫测定）正在通过提供更快、更准确的感染检测来改变市场。一个关键趋势是转向便携式快速诊断，使医疗保健提供者能够快速诊断偏远地区或疫情易发地区的患者。这些进步正在改善病毒感染的早期检测和管理，减少疾病传播。随着全球公共卫生问题日益严重，对先进、用户友好的检测解决方案的需求不断增加，这使其成为医疗诊断领域关注的关键领域。
报告范围和节肢动物传播病毒感染检测市场细分
|
属性 |
节肢动物传播病毒感染检测关键市场洞察 |
|
涵盖的领域 |
|
|
覆盖国家 |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Key Market Players |
Thermo Fisher Scientific, Inc. (U.S.); BioMérieux (France); Hologic, Inc. (U.S.); EUROIMMUN Medizinische Labordiagnostika AG (Germany); Bio-Rad Laboratories, Inc. (U.S.); F. Hoffmann-La Roche Ltd (Switzerland); InBios International Inc. (U.S.); Quest Diagnostics Incorporated (U.S.); CERTEST BIOTEC (Spain); Response Biomedical (Canada); Chembio Diagnostics, Inc. (U.S.); Abbott (U.S.) |
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. |
Arthropod-Borne Viral Infections Testing Market Definition
Arthropod-Borne Viral Infections Testing refers to the diagnostic processes used to detect viruses transmitted by arthropods, such as mosquitoes, ticks, and fleas. These viruses, including dengue, Zika, chikungunya, and West Nile, cause diseases that can lead to severe health complications. Testing methods include molecular tests, immunoassays, and culture-based approaches, which help in the timely identification and management of these infections to prevent outbreaks and ensure appropriate treatment.
Arthropod-Borne Viral Infections Testing Market Dynamics
Drivers
- Rising Prevalence of Arthropod-Borne Diseases
The increasing incidence of arthropod-borne diseases such as dengue, Zika, chikungunya, and West Nile virus significantly drives the demand for advanced testing solutions. These viral infections, transmitted primarily through mosquitoes, have seen a notable rise in global cases due to factors such as climate change, urbanization, and increased travel. For instance, dengue cases have surged dramatically in tropical and subtropical regions, prompting urgent healthcare responses. Consequently, there is a pressing need for efficient and reliable diagnostic methods to facilitate early detection and management of these diseases, ultimately enhancing patient outcomes and public health initiatives. This trend underscores the critical need for innovative testing solutions in the market.
- Advancements in Molecular Diagnostic Technologies
Advancements in molecular diagnostic technologies, including polymerase chain reaction (PCR) and next-generation sequencing (NGS), are pivotal in driving growth in the arthropod-borne viral infections testing market. These technologies allow for rapid and precise detection of viral pathogens, significantly enhancing diagnostic accuracy. PCR techniques can identify specific genetic material of viruses within hours, while NGS provides comprehensive genomic data, facilitating the understanding of viral mutations and epidemiology. As healthcare providers increasingly adopt these innovative testing solutions, they can respond more effectively to outbreaks and manage patient care, ultimately propelling the demand for molecular diagnostics in this critical sector of infectious disease testing.
Opportunities
- Telemedicine and Remote Testing Solutions
The rise of telemedicine and remote patient monitoring presents a significant opportunity for the arthropod-borne viral infections testing market, particularly through the development and distribution of at-home testing kits. These kits allow individuals in underserved regions to access diagnostic solutions conveniently, eliminating the barriers posed by distance and healthcare accessibility. As telehealth continues to grow, patients can conduct tests in the comfort of their homes and receive results quickly, facilitating timely medical intervention. This shift enhances patient engagement and reduces the burden on healthcare facilities, driving demand for innovative testing products tailored for remote use in the management of viral infections.
- Vaccine Development and Monitoring
The development of new vaccines for arthropod-borne diseases presents a significant market opportunity for specialized diagnostic solutions focused on efficacy and safety testing. As public health initiatives strive to combat viral infections such as dengue and Zika, the demand for comprehensive testing methods becomes essential to ensure vaccine performance and patient safety. Diagnostic tools that can accurately assess immune responses and identify adverse effects will be crucial in evaluating vaccine candidates during clinical trials and post-marketing surveillance. This need for rigorous testing supports vaccine development and fosters innovation in the diagnostics sector, driving growth and investment in cutting-edge testing technologies.
Restraints/Challenges
- High Cost of Molecular Diagnostic Technologies
The high costs associated with the development and implementation of advanced molecular diagnostic technologies, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), pose a significant challenge in the arthropod-borne viral infections testing market. These sophisticated technologies require substantial investment in equipment, reagents, and training, making them less accessible for smaller laboratories and healthcare providers, especially in low-resource settings. This financial barrier can lead to disparities in diagnostic capabilities, limiting timely and accurate testing in regions most affected by arthropod-borne diseases. Consequently, this challenge hampers effective disease management and control efforts, highlighting the need for more affordable and accessible testing solutions.
- Inconsistent Disease Surveillance
Variability in disease surveillance systems poses a significant restraint on the arthropod-borne viral infections testing market, as it can lead to incomplete and inconsistent data regarding infection prevalence. In many regions, particularly in low-resource settings, surveillance efforts may be underfunded or poorly organized, resulting in gaps in information about disease outbreaks and transmission patterns. This lack of reliable data can hinder effective public health responses, as decision-makers rely on accurate statistics to allocate resources and implement control measures. Consequently, the uncertainty in disease prevalence diminishes the perceived need for testing, negatively impacting market demand and stifling advancements in diagnostic capabilities.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Arthropod-Borne Viral Infections Testing Market Scope
The market is segmented on the basis of test type and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Test Type
- Molecular Tests
- Cultural Tests
- Immunoassays
- Others
End User
- Hospitals
- Research Centers
- Diagnostic Centers
Arthropod-Borne Viral Infections Testing Market Regional Analysis
The market is analysed and market size insights and trends are provided by country, test type, and end-user as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the arthropod-borne viral infections testing market, driven by the swift advancement of diagnostic technologies in the region. The integration of innovative solutions, such as PCR and next-generation sequencing, enhances testing accuracy and efficiency. Furthermore, robust healthcare infrastructure and substantial investment in research contribute to the region's leadership in this market.
The Asia-Pacific region is projected to experience substantial growth in the arthropod-borne viral infections testing market from 2024 to 2031, primarily due to its large population at risk for infections. The high prevalence of arboviruses in this area further exacerbates the demand for effective diagnostic solutions. Additionally, increasing public health awareness and improved healthcare infrastructure are likely to drive this market expansion in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Arthropod-Borne Viral Infections Testing Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Arthropod-Borne Viral Infections Testing Market Leaders Operating in the Market Are:
- Thermo Fisher Scientific, Inc. (U.S.)
- BioMérieux (France)
- Hologic, Inc. (U.S.)
- EUROIMMUN Medizinische Labordiagnostika AG (Germany)
- Bio-Rad Laboratories, Inc. (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- InBios International Inc. (U.S.)
- Quest Diagnostics Incorporated（美国）
- CERTEST BIOTEC（西班牙）
- Response Biomedical（加拿大）
- Chembio Diagnostics, Inc.（美国）
- 雅培（美国）
节肢动物传播病毒感染检测市场的最新发展
- 2024 年 5 月，全球健康创新技术 (GHIT) 基金宣布投资约 16.4 亿日元（1080 万美元），旨在推进四个项目，重点是开发针对疟疾和被忽视的热带疾病的新疗法。这项资助计划凸显了该组织致力于解决服务不足地区的关键健康挑战。通过支持创新药物开发，GHIT 旨在增强治疗选择并改善全球受影响人群的健康状况
- 2023 年 5 月，安斯泰来制药公司宣布向全球健康创新技术基金捐款，该基金旨在支持开发针对各种传染病的药物、诊断工具和疫苗。这项捐款主要针对那些往往缺乏足够资金和资源、但未被充分认识的热带疾病。通过投资这项计划，安斯泰来制药寻求改善全球卫生成果并解决传染病管理方面的关键差距
- 2022 年 7 月，Mylab Discovery Solutions 推出了其创新的疾病检测试剂盒“PathoDetect 扩展季风发热检测板”，该试剂盒展示了令人印象深刻的灵敏度和特异性。这种先进的检测板可以有效区分多种传染病，包括疟疾、基孔肯雅病、登革热、寨卡病毒、钩端螺旋体病、沙门氏菌和利什曼病寄生虫。该检测试剂盒能够准确识别多种病原体，增强了季风季节的诊断能力，解决了受影响地区面临的重大健康挑战
- 2021 年 11 月，瑞士医疗技术公司 Achico 宣布开发专门针对登革热的诊断试剂盒。这些创新的检测试剂盒利用了该公司的 DNA 适体技术平台，该平台已被证明可有效诊断 COVID-19。通过将这项先进技术应用于登革热诊断，Achico 旨在提高这种重大传染病的检测准确性和效率
- 2021 年 11 月，瑞士医疗技术公司 Achico 公布了开发登革热诊断试剂盒的计划。这些创新的检测试剂盒将利用该公司的 DNA 适体技术平台，该平台已证明其在诊断 COVID-19 方面的有效性。这一进步旨在增强登革热的诊断能力，满足对可靠检测解决方案日益增长的需求
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
